Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
verfasst von:
Allison D Ta, Li-Yueh Hsu, Christopher A Miller, Anders M Greve, Hannah Conn, Susanne Winkler, Peter Kellman, Kim-Lien Nguyen, Sujata M Shanbhag, Marcus Y Chen, W Patricia Bandettini, Andrew E Arai
In this study we evaluate the diagnostic accuracy of myocardial perfusion pixel maps for detecting coronary artery disease (CAD). We also compare the performance of perfusion pixel maps with and without myocardial segmentation.
Methods
Forty-seven patients had 1.5T steady state free precession, regadenoson stress perfusion CMR and either a ≤ 30% coronary narrowing by CT angiography (CTA) or a ≥70% stenosis by invasive coronary angiography (ICA). CMR perfusion pixel maps were generated by a model-constrained deconvolution with and without the myocardial segmentation. The two independent observers were blinded to clinical information.
Anzeige
Results
Significant coronary stenoses were present in 22 of 47 patients. The diagnostic accuracy of pixel-wise quantification of myocardial perfusion is summarized in Table 1. All of the pixel maps were of diagnostic quality (Figure 1). Interobserver agreement was excellent for ROI guided pixel maps (kappa 0.87). Agreement between readers for perfusion pixel-maps made without ROIs was kappa = 0.59. One reader tended towards higher sensitivity while the other reader favored specificity.
Table 1
Diagnostic Accuracy of Pixel-wise Quantification of Regadenoson Perfusion
Sensitivity
Specificity
Accuracy
PPV
NPV
No ROIs
Obs 1
0.82
0.88
0.85
0.86
0.85
Obs 2
0.95
0.6
0.77
0.68
0.94
Epi/Endo ROIs
Obs 1
0.77
0.96
0.87
0.94
0.83
Obs 2
0.86
0.92
0.89
0.9
0.88
Figure 1
Perfusion Pixel-Maps in a patient with 85% LAD and RCA stenoses. A) stress perfusion image, B) pixel map generated using Epi/Endo ROIs, C) pixel map generated without ROI's. D), E) and F) are the rest images and perfusion maps.
×
Conclusions
Fully quantitative stress perfusion analysis at a pixel level has significant potential in clinical settings. As evidence of feasibility, diagnostic quality perfusion pixel maps could be generated without the spatial constraints of the epicardial and endocardial ROIs.
Funding
ADT is supported by the Sarnoff Cardiovascular Research Foundation. CM is supported by the National Institutes of Health Research, UK. ADT, LH, HC, SW, KN, PK, SS, MC, PB, and AA are supported by the National Institutes of Health, USA.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
verfasst von
Allison D Ta Li-Yueh Hsu Christopher A Miller Anders M Greve Hannah Conn Susanne Winkler Peter Kellman Kim-Lien Nguyen Sujata M Shanbhag Marcus Y Chen W Patricia Bandettini Andrew E Arai
Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Update Radiologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
